Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

44.3K
Overview
44.3K
Hepatitis01:25

Hepatitis

99
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
99
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

28
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion...
28

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Replicating viral vectors as HIV vaccines: summary report from the IAVI-sponsored satellite symposium at the AIDS vaccine 2009 conference.

Biologicals : journal of the International Association of Biological Standardizationยท2010
Same author

Replicating viral vectors as HIV vaccines Summary Report from IAVI Sponsored Satellite Symposium, International AIDS Society Conference, July 22, 2007.

Biologicals : journal of the International Association of Biological Standardizationยท2008
Same author

A global lab against influenza.

Science (New York, N.Y.)ยท2001
Same author

Planning for the next pandemic of influenza.

Reviews in medical virologyยท2001
Same author

Epidemiology of hepatitis B infection in the Western Pacific and South East Asia.

Gutยท1996
Same author

Some thoughts on the children's vaccine initiative.

Biologicals : journal of the International Association of Biological Standardizationยท1995

Related Experiment Video

Updated: May 5, 2026

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

6.6K

Immunisation against hepatitis B in Taiwan

I D Gust1

  • 1CSL Limited, Victoria, Australia.

Gut
|January 1, 1996
PubMed
Summary

Taiwan

Area of Science:

  • Public Health
  • Epidemiology
  • Vaccinology

Background:

  • Hepatitis B is a significant public health concern in Taiwan, with over 15% of adults being chronic carriers.
  • Long-term complications such as chronic active hepatitis, cirrhosis, and liver cancer are prevalent.

Purpose of the Study:

  • To evaluate the impact of a decade-long national Hepatitis B immunization program implemented in Taiwan.
  • To assess the program's effectiveness in reducing the prevalence of Hepatitis B virus (HBV) infection and transmission.

Main Methods:

  • A national immunization strategy targeting newborns, susceptible school children, and young adults was implemented in 1984.
  • The study analyzes data over a ten-year period to assess the program's outcomes.

More Related Videos

Multicellular Human Alveolar Model Composed of Epithelial Cells and Primary Immune Cells for Hazard Assessment
09:27

Multicellular Human Alveolar Model Composed of Epithelial Cells and Primary Immune Cells for Hazard Assessment

Published on: May 6, 2020

11.4K
A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

2.2K

Related Experiment Videos

Last Updated: May 5, 2026

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

6.6K
Multicellular Human Alveolar Model Composed of Epithelial Cells and Primary Immune Cells for Hazard Assessment
09:27

Multicellular Human Alveolar Model Composed of Epithelial Cells and Primary Immune Cells for Hazard Assessment

Published on: May 6, 2020

11.4K
A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

2.2K

Main Results:

  • A significant decrease in the prevalence of Hepatitis B surface antigen (HBsAg) was observed among young children.
  • Evidence suggests a reduction in horizontal transmission of HBV among older children.

Conclusions:

  • The national Hepatitis B vaccination program has been effective in reducing infection rates in young populations.
  • The program shows promise in controlling the long-term burden of Hepatitis B in Taiwan.